Commonwealth Equity Services
ONC

Commonwealth Equity Services’s BeOne Medicines Ltd ONC Stock Holding History

Commonwealth Equity Services’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$520K Buy
1,825
+66
+4% +$19.4K ﹤0.01% 3285
2026
Q1 		$522K Sell
1,759
-712
-29% -$230K ﹤0.01% 3172
2025
Q4 		$751K Buy
2,471
+1,709
+224% +$559K ﹤0.01% 2825
2025
Q3 		$259K Buy
+762
New +$231K ﹤0.01% 3761

Other funds holding ONC

AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
AG
AIA Group Hong Kong $7.95B AUM 28.94% 1-Year Est. Return
SC
Slow Capital Greenbrae, California $857M AUM 38.3% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Commonwealth Equity Services's ONC Position: Q2 2026 in Review

Commonwealth Equity Services increased its BeOne Medicines Ltd (ONC) stake by 3.8% in Q2 2026, buying an estimated $19.4K and bringing the position to 1,825 shares worth $520K. The position accounts for ﹤0.01% of the portfolio, ranked #3285.

Commonwealth Equity Services first reported a position in ONC in Q3 2025 and has held it in 4 quarters since. The position peaked at $751K in Q4 2025. 67 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Commonwealth Equity Services held 1,825 shares of BeOne Medicines Ltd worth $520K as of Q2 2026.
  • Commonwealth Equity Services bought 66 BeOne Medicines Ltd shares in Q2 2026, an estimated $19.4K.
  • BeOne Medicines Ltd made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #3285 holding.
  • Commonwealth Equity Services first reported a position in BeOne Medicines Ltd in Q3 2025 and has held it in 4 quarters since.
  • Commonwealth Equity Services's BeOne Medicines Ltd position peaked at $751K in Q4 2025.
  • 67 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.